Skip to main content
. 2007 Jun;2(2):235–240.

Figure 2.

Figure 2

Bright field (ac) and photoluminescent (df) images of SK-BR-3 cells targeted with PbS-QD/anti-HER2 (~50 nM) (a, d) and PbS-QD/anti-IgG (~50 nM) (b, e) bioconjugates. SK-BR-3 cells incubated with PBS are used as control (c, f). All images are in the same scale with a 50 μm scale bar (40x).

Abbreviations: IgG, immunoglobulin G; PbS, lead sulfide; PBS, phosphate-buffered saline; QD, quantum dots.